The FDA plans to hold a public meeting this fall to hear from nanotech researchers on their work in the field of drug discovery. The meeting is being scheduled so that the agency can gather more information on how researchers are developing new materials that can alter the way a drug is delivered. Nanotech materials are microscopic in size, which can change the way a drug is metabolized or allow a therapy to reach previously out-of-reach sites in the body.
- here's the report [1] from Nanotechwire
Links:
[1] http://nanotechwire.com/news.asp?nid=3216